Campbell & Co Investment Adviser’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.32M Buy
20,928
+20,072
+2,345% +$8.77M 0.44% 19
2026
Q1
$395K Buy
+856
New +$433K 0.02% 805
2025
Q4
Sell
-12,600
Closed -$5.64M 1262
2025
Q3
$5.64M Buy
12,600
+8,055
+177% +$3.87M 0.43% 20
2025
Q2
$2.47M Buy
4,545
+767
+20% +$401K 0.16% 191
2025
Q1
$1.87M Buy
3,778
+2,102
+125% +$1.16M 0.14% 217
2024
Q4
$875K Buy
1,676
+100
+6% +$52.1K 0.07% 442
2024
Q3
$774K Buy
+1,576
New +$734K 0.06% 537
2022
Q4
Sell
-4,218
Closed -$791K 885
2022
Q3
$791K Buy
4,218
+1,246
+42% +$268K 0.18% 178
2022
Q2
$597K Buy
+2,972
New +$697K 0.16% 214
2020
Q1
Sell
-1,815
Closed -$358K 266
2019
Q4
$358K Buy
+1,815
New +$340K 0.11% 351
2019
Q3
Sell
-5,628
Closed -$984K 673
2019
Q2
$984K Buy
5,628
+2,802
+99% +$480K 0.45% 25
2019
Q1
$537K Buy
+2,826
New +$502K 0.26% 96

Other funds holding ISRG

Campbell & Co Investment Adviser's ISRG Position: Q2 2026 in Review

Campbell & Co Investment Adviser increased its Intuitive Surgical (ISRG) stake by 2,345% in Q2 2026, buying an estimated $8.77M and bringing the position to 20,928 shares worth $8.32M. The position accounts for 0.44% of the portfolio, ranked #19.

Campbell & Co Investment Adviser first reported a position in ISRG in Q1 2019 and has held it in 12 quarters since. 1,158 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Campbell & Co Investment Adviser held 20,928 shares of Intuitive Surgical worth $8.32M as of Q2 2026.
  • Campbell & Co Investment Adviser bought 20,072 Intuitive Surgical shares in Q2 2026, an estimated $8.77M.
  • Intuitive Surgical made up 0.44% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #19 holding.
  • Campbell & Co Investment Adviser first reported a position in Intuitive Surgical in Q1 2019 and has held it in 12 quarters since.
  • 1,158 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.